Literature DB >> 23549397

Precursors to lymphoproliferative malignancies.

Lynn R Goldin1, Mary L McMaster, Neil E Caporaso.   

Abstract

We review monoclonal B-cell lymphocytosis (MBL) as a precursor to chronic lymphocytic leukemia and monoclonal gammopathy of undetermined significance (MGUS) as a precursor to plasma cell disorders. These conditions are present in the general population and increase with age. These precursors aggregate with lymphoproliferative malignancies in families suggesting shared inheritance. MBL and MGUS may share some of the same risk factors as their related malignancies but data are limited. Although these conditions are characterized by enhanced risk for the associated malignancy, the majority of individuals with these conditions do not progress to malignancy. A key focus for current work is to identify markers that predict progression to malignancy.

Entities:  

Mesh：

Year:  2013        PMID： 23549397      PMCID： PMC3616401          DOI： 10.1158/1055-9965.EPI-12-1348

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  83 in total

Review 1.  Prevalence of monoclonal B-cell lymphocytosis: a systematic review.

Authors:  Youn K Shim; Dannie C Middleton; Neil E Caporaso; Jane M Rachel; Ola Landgren; Fatima Abbasi; Elizabeth S Raveche; Andy C Rawstron; Alberto Orfao; Gerald E Marti; Robert F Vogt
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

2.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

3.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; L Joseph Melton; Colin L Colby; Terry M Therneau; Raynell Clark; Shaji K Kumar; Arthur Bradwell; Rafael Fonseca; D F Jelinek; S Vincent Rajkumar
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

4.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

5.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Authors:  Andy C Rawstron; Martin R Yuille; Julie Fuller; Matthew Cullen; Ben Kennedy; Stephen J Richards; Andrew S Jack; Estella Matutes; Daniel Catovsky; Peter Hillmen; Richard S Houlston
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.

Authors:  Li-Na Lee; I-Shiow Jan; Hwei-Fang Tien; Jen-Shiou Lin; Shyh-Chyi Lo; Wern-Cherng Cheng
Journal:  J Formos Med Assoc       Date:  2002-02       Impact factor: 3.282

9.  Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

10.  The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.

Authors:  Adam L Cohen; Rami Sarid
Journal:  Thromb Res       Date:  2009-02-03       Impact factor: 3.944
View more
  10 in total

Review 1.  New challenges in evaluating anemia in older persons in the era of molecular testing.

Authors:  David P Steensma
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 2.  Epidemiology and Etiology of Leukemia and Lymphoma.

Authors:  Jordan A Baeker Bispo; Paulo S Pinheiro; Erin K Kobetz
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

3.  Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.

Authors:  Jonathan N Hofmann; Sham Mailankody; Neha Korde; Ye Wang; Nishant Tageja; Rene Costello; Adriana Zingone; Malin Hultcrantz; Michael N Pollak; Mark P Purdue; Ola Landgren
Journal:  Obesity (Silver Spring)       Date:  2017-06-11       Impact factor: 5.002

4.  Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.

Authors:  Jelle Vlaanderen; Max Leenders; Marc Chadeau-Hyam; Lützen Portengen; Soterios A Kyrtopoulos; Ingvar A Bergdahl; Ann-Sofie Johansson; Dennie D G A J Hebels; Theo M C M de Kok; Paolo Vineis; Roel C H Vermeulen
Journal:  BMC Genomics       Date:  2017-03-20       Impact factor: 3.969

5.  An atlas of B-cell clonal distribution in the human body.

Authors:  Wenzhao Meng; Bochao Zhang; Gregory W Schwartz; Aaron M Rosenfeld; Daqiu Ren; Joseph J C Thome; Dustin J Carpenter; Nobuhide Matsuoka; Harvey Lerner; Amy L Friedman; Tomer Granot; Donna L Farber; Mark J Shlomchik; Uri Hershberg; Eline T Luning Prak
Journal:  Nat Biotechnol       Date:  2017-08-21       Impact factor: 54.908

6.  SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization.

Authors:  Mateusz Nowicki; Agnieszka Wierzbowska; Emilia Stec-Martyna; Dominika Kulczycka-Wojdala; Grzegorz Nowicki; Anna Szmigielska-Kapłon
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

7.  Concurrent B Cell Acute Lymphoblastic Lymphoma/Leukemia and Monoclonal B Cell Lymphocytosis: A Case Report with Extensive Molecular Analysis.

Authors:  Maryam Mehdipour Dalivand; Parastou Tizro; Julie Partain; Anita Aggarwal; Jack Lichy; Francisco Mot Ara; Victor E Nava
Journal:  Case Rep Hematol       Date:  2022-04-21

Review 8.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09

9.  Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.

Authors:  Eleanor Kane; Daniel Painter; Alexandra Smith; Maxine Lamb; Steven E Oliver; Russell Patmore; Eve Roman
Journal:  Int J Cancer       Date:  2019-11-23       Impact factor: 7.396

10.  Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.

Authors:  Maxine Je Lamb; Alexandra Smith; Daniel Painter; Eleanor Kane; Timothy Bagguley; Robert Newton; Debra Howell; Gordon Cook; Ruth de Tute; Andrew Rawstron; Russell Patmore; Eve Roman
Journal:  BMJ Open       Date:  2021-02-22       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.